Pharmaceutical companies step up their lobbying efforts in the EU: to invest more than ever and to secure their access to decision-makers in the European Commission. Currently in focus: the FTA TTIP.
REUTERS
EU-Kommission in Brüssel: Pharmakonzerne sichern sich Zugang zu Entscheidern